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I t is unclear whether in patients with severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2)
infection, acute kidney injury (AKI) results from direct
infection of the kidneys or from complications arising in
the course of coronavirus disease 2019 (COVID-19). Re-
ports of urinary abnormalities in COVID-19 patients,S1
positive staining of tubules with viral antigens and com-
plement components in one autoptic series,1 visualization
of viral particles in tubular epithelial cells and podocytes
on ultrastructural examination in another,2 and isolation
of SARS-CoV-2 in urineS2,S3 raised the possibility of a
SARS-CoV-2 nephropathy. We describe the clinical
course, renal histopathology, and molecular testing of
renal tissue, serum, and urinary samples of a critically
ill patient with COVID-19 who developed oligoanuric
AKI. The absence of viral genetic material in tested spec-
imens and lack of histologic evidence for cytopathic ef-
fects do not support the hypothesis of the kidneys as
target organs of SARS-CoV-2 infection.
CASE PRESENTATION
A 49-year-old overweight but otherwise healthy male
was admitted to the emergency room for dyspnea,cough, and fever. He had no known contacts with
SARS-CoV-2–positive individuals, nor history of
recent travel abroad. His peripheral capillary oxygen
saturation (SpO2) was 98%, heart rate 112 bpm, and
body temperature 100.4 F. SpO2 worsened over a few
hours, requiring oxygen therapy. A chest computed
tomography scan showed interstitial pneumonia with
ground-glass opacities. As he failed to meet strict
epidemiologic criteria for COVID-19, imaging findings
were deemed compatible with bacterial infection.
Azithromycin and piperacillin/tazobactam were star-
ted. Real-time reverse transcriptase polymerase chain
reaction (RT-PCR) for SARS-CoV-2 on nasal and
oropharyngeal swabs tested positive and he was
transferred to the infectious diseases unit (day 2 since
hospitalization), where he received the institutional
treatment protocol for COVID-19 (200 mg bid
hydroxychloroquine and 400/100 mg bid lopinavir-
ritonavir). SpO2 deteriorated to 84% on high-flow
oxygen therapy. By day 6, he developed acute respi-
ratory distress syndrome (ARDS) and was transferred
to the general intensive care unit, where after a trial of
noninvasive mechanical ventilation he was sedated,
intubated, curarized, and put on lung-protective me-
chanical ventilation. On day 12, he wasKidney International Reports (2020) 5, 1100–1105
Figure 1. Morphologic features of acute tubular injury on renal biopsy of a critically ill patient with coronavirus disease 2019 (COVID-19) and
acute kidney injury. (a) Diffuse tubular injury and focal tubular necrosis with several tubules showing intraluminal epithelial sloughing (asterisks;
periodic acid–Schiff [PAS], original magnification 400); (b) epithelial cells showed an increased proliferative index, revealed by Ki67 positivity
(Ki67þPAS, original magnification 400). (c) Some tubules displayed mixed casts formation (Masson trichrome, original magnification 400). (d)
Several tubules had intraluminal red blood cells (arrow) whereas glomeruli appeared normal overall (methenamine-silver, original
magnification 400). (e) Epithelial cells showed regenerative changes with frequent mitotic figures (asterisks; PAS, original
magnification 600).
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by acute heart failure with severely reduced ejecton
fraction and hypotension requiring fluid resuscitation
and inotropes. In the meantime (day 8), he developed
oligoanuric AKI requiring overall twenty 12-hour
sustained low-efficiency dialysis (SLED) sessions
with citrate regional anticoagulation.3 On day 19, he
was transferred to the intensive care section of the
renal unit. Urinary output slowly increased without
amelioration of renal function. Oropharyngeal swabs
repeatedly tested positive for SARS-CoV-2 RT-PCR. A
kidney biopsy was performed on day 37. The patient
later became afebrile and was successfully weaned off
both ventilation and tracheostomy and transferred to
the inpatient clinic of the renal unit. He is currently
doing well and is afebrile with 96% SpO2 in ambient
air. Renal function is slowly but steadily amelioratingKidney International Reports (2020) 5, 1100–1105with no current need for dialysis (last session on day
34; time of writing: day 51).
Kidney biopsy showed extensive acute tubular
injury (ATI) with marked regenerative changes and
focal acute tubular necrosis (Figure 1). No nuclear
atypia, syncytia, or inclusion bodies were observed.
An extensive immunohistochemical stain panel for
CD3, CD20, CD68, and CD163 showed minimal, focal
lymphocytic tubulitis and mild diffuse mixed inter-
stitial inflammation (Figure 2). Immunofluorescence on
frozen tissue including immunostaining for IgG, IgA,
IgM, kappa and lambda light chains, C3, C4d, C1q,
C5b9, and fibrinogen was negative or nonspecific. Viral
particles were not observed on ultrastructural exami-
nation (Figure 3).
Real-time RT-PCR (per CDC guidelines, https://
www.cdc.gov/coronavirus/2019-ncov/lab/) on frozen1101
Figure 2. Immunohistochemical characterization of the interstitial inflammatory infiltrate on renal biopsy of a critically ill patient with coro-
navirus disease 2019 (COVID-19) and acute kidney injury. (a) Mild diffuse interstitial inflammatory infiltrate in the setting of interstitial edema and
acute tubular injury with tubuloepithelial flattening and simplification (hematoxylin and eosin, original magnification 200 and 100 [inset]).
Immunohistochemistry studies showed (b) diffuse leukocyte common antigen (LCA) (CD45)–positive infiltrate (LCA þ periodic acid–Schiff [PAS],
original magnification 200 and 100 [inset]), with (c) a scarce B-cell component (CD20 þ PAS, original magnification 200 and 100 [inset]),
but relevant presence of (d) T cells (CD3 þ PAS, original magnification 200 and 100 [inset]) and CD68–CD163–positive macrophages (e
[CD68] and f [CD163], original magnification 200 and 100 [insets]). LCA, as the name implies, is a pan-leukocyte marker; CD3 and C20 are T
cell– and B cell–specific, respectively; CD68 and CD163 are both macrophage markers. Overall, the inflammatory infiltrate was mixed and
nonspecific, as commonly observed in a variety of conditions, including the typical inflammation associated with tubular atrophy/interstitial
fibrosis. CD, cluster of differentiation.
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Figure 3. Ultrastructural findings on renal biopsy of a critically ill patient with coronavirus disease 2019 (COVID-19) and acute kidney injury. Low
magnification of a glomerulus showing overall well-preserved architecture, with patent capillaries and irregular flattening of podocyte foot
processes. (a) Effacement of the latter was minimal and confined to a few areas (bar ¼ 5 mm). (b) A degenerating epithelial cell with a pyknotic
nucleus is consistent with acute tubular injury (bar ¼ 5 mm). (c) A blood vessel, likely a peritubular capillary, shows degenerating endothelial
cells (bar ¼ 2 mm). Higher magnification of the same image as in (c), highlighting (d) the presence of a “nuclear body” (arrow) in a fibroblast
adjacent to the peritubular capillary (bar ¼ 2 mm). Nuclear bodies are thought to be the expression of “cellular hyperactivity” due to several
causes, including physiological and disease states.
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the biopsy was negative for SARS-CoV-2 RNA.DISCUSSION
During the 2003 Hong Kong outbreak of SARS, AKI
occurred in 8 patients out of a series of 536 (6.7%).4
AKI was more frequently reported in Middle East
respiratory syndrome (MERS), although with a wide
variability, reaching a prevalence of 58% in one small
series of critically ill patients.5,S4 Early reports of
COVID-19 showed a low incidence of AKI (0.5%–
15%S2,S5–S7). SARS-CoV and MERS-CoV differ in their
point of entry into cells, the former entering via
angiotensin-converting enzyme-2 and the latter via
dipeptidyl peptidase-4, both extensively expressed by
human kidney epithelial cells.S8,S9 Despite extensiveKidney International Reports (2020) 5, 1100–1105expression, in vitro studies showed that while both
viruses could enter and replicate in immortalized hu-
man kidney epithelial cells, only MERS-CoV deter-
mined cytopathic effects (cell detachment and death),
therefore implicating a possible causal relationship
between kidney infection and AKI in MERS.6 The first
live COVID-19 patient who underwent a kidney biopsy
was a non-critically ill African American female with
prior comorbidities (including chronic kidney disease)
who developed AKI that eventually required dialysis.
She never developed ARDS. As kidney biopsy showed
collapsing focal segmental glomerulosclerosis, a high-
interferon state induced by viral infection in the
setting of apolipoprotein-1 high-risk status was hy-
pothesized, and no evidence for virus infection was
established based on in situ RNA hybridization and
ultrastructural examination.71103
Table 1. Key teaching points
1. Real-time reverse transcriptase polymerase chain reaction for SARS-CoV-2 on frozen
kidney tissue, serum, and urinary samples collected the same day the kidney biopsy
was performed were negative despite repeatedly positive nasal and oropharyngeal
swabs, thus ruling out direct infection of the kidney.
2. Glomerular and vascular lesions were absent. No morphologic correlate of cytopathy
was observed (e.g., syncytia, inclusion bodies, nuclear atypia). Viral particles were
absent on ultrastructural examination. The predominant histologic picture was that of
acute tubular injury, most likely related to acute heart failure, and therefore renal
hypoperfusion.
3. This case does not support viral tropism of the kidney by SARS-CoV-2 inducing acute
kidney injury as previously suggested by autopsy series, highlighting the necessity for
experimental proof of productive infection of renal cells to support a SARS-CoV-2
nephropathy and not merely morphologic data.
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
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encompassing (i) nephropathies resulting from systemic
(e.g., capillary leak due to cytokine storm, as in
Dengue-associated AKIS10,S11) or local (e.g., in situ an-
tigen deposition, as in hepatitis B virus–associated
membranous nephropathy) consequences of the infec-
tion without actual infection of renal cells, and (ii)
nephropathies due to infection of the kidneys (i.e.,
viral tropism of the kidney), as with direct cytopathic
effects on tubular epithelial cells in BK virus ne-
phropathy and on endothelial cells in Hantavirus
nephropathy.S12 AKI during acute viral illness can
derive from a plethora of causes. In SARS-related AKI,
there was no evidence of viral tropism of the kidney
despite detection of viral RNA fragments by RT-PCR in
urinary samplesS13 and distal tubular cells.S14 Thus,
kidney injury was ascribed to hemodynamic changes
secondary to cytokine storm and ensuing capillary leak
syndrome, rather than to direct target organ infection.4
An in vitro study, however, showed that productive
infection of tubular and mesangial cells was attained by
SARS-CoV, albeit with no cytopathic effect.8 In the
current dramatic SARS-CoV-2 outbreak, indirect evi-
dence from autopsy series raised the possibility of viral
kidney tropism leading to AKI, although the low
incidence of the latter argues against it.1,2
In their series of 6 COVID-19 autopsies, Diao et al.1
reported ATI, and in contrast with our biopsy, tubu-
lointerstitial nephritis with a predominant macrophagic
infiltrate and deposition of the terminal complement
cascade component C5b9 along tubules. Immunohisto-
chemistry for SARS-CoV-2 antigen nucleocapsid protein
was positive in epithelial cells, which showed syncytia,
a morphologic correlate of viral cytopathy, leading the
authors to argue that altogether these findings proved
viral tropism of the kidney. In a further autopsy series of
26 cases by Su et al.,2 similar morphologic and immu-
nohistochemical findings were reported, with the
addition of ultrastructural evidence of viral particles in
both podocytes and tubular epithelial cells, with fea-
tures similar to those of MERS-CoV and SARS-CoV.21104Based on these findings, the authors openly state that
SARS-CoV-2 infection of renal parenchyma occurs, the
virus being a direct effector of ATI. These claims,
however, are based on fragile grounds.
Syncytia by light microscopy (described by Diao
et al.1 but not Su et al.2) and viral particles by ultra-
structural examination can be difficult to unequivo-
cally identify, whereas the inherent limits of such
techniques can be partly overcome with the aid, for
example, of in situ hybridization. Immunohistochem-
istry for viral antigens as compared to genetic material
demonstration is intrinsically limited by low speci-
ficity; this also applies to SARS-CoV-2 nucleocapsid
protein immunohistochemistry, as reported by Larsen
et al.7 More importantly, neither observation provides
reproducible proof of viral tropism with productive
infection, which would require the concurrent
demonstration of renal cell infection (i.e., viral entry)
together with viral replication and/or cytopathy.S15 In
fact, even the presence of viral antigens or genetic
material in organs might not necessarily translate into
tissue damage, as with cytomegalovirus infection.9
Finally, ATI is notoriously hard, if not impossible, to
differentiate from autolysis, one of the most common
findings in autopsy kidneys, and although Su et al.2
reported no cases showed autolysis in their series, it
is unclear how they excluded it, as no reliable histo-
logic criteria exist to tell them apart; they do, however,
state that all autopsies were performed with a post-
mortem interval of less than 6 hours, which might be
short enough to prevent significant autolysis.S16,S17
Regardless, the attribution of ATI to viral infection
based solely on the observation of sparse viral particles
is questionable, considering the multitude of compli-
cations capable of inducing ATI that a critically ill
patient with ARDS commonly experiences in the
intensive care unit.
Altogether, the histologic features we observed were
consistent with ATI of any etiology, and particularly
ischemic ATI/acute tubular necrosis,S18 which fits well
with prolonged hypotension. Tubulitis and nonspecific
interstitial inflammation were also observed, but the
former was minimal, whereas the latter was confined to
areas of initial tubular atrophy, which is hardly
consistent with a diagnosis of acute interstitial nephritis.
By failing to show evidence of the virus on serum,
urine, and renal tissue using the most sensitive method
available (real-time RT-PCR), despite repeatedly posi-
tive nasopharyngeal swabs, our case stands as evidence
against the hypothesis of a SARS-CoV-2 nephropathy.
However, we are reporting a single case, and formal
proof can only derive from functional studies in a
rigorous experimental setting, such as those conducted
for MERS-CoV.6 Our case hopefully shed some light onKidney International Reports (2020) 5, 1100–1105
GM Rossi et al.: Kidney Biopsy of a Critically Ill COVID-19 Patient NEPHROLOGY ROUNDSkidney involvement (or, rather, lack thereof) by SARS-
CoV-2, while showing how pathomorphology alone is
insufficient to prove or disprove viral tropism, even
when supported by sophisticated techniques such as
PCR and in situ hybridization.
Larger studies on kidney biopsies of patients with
COVID-19 are needed to definitively rule out the exis-
tence of a SARS-CoV-2 nephropathy, provided they are
coupledwith scientifically sound experimental evidence
of direct infection of renal cells by the virus (Table 1).
During this pandemic, we grew accustomed to unor-
thodox means of diffusion of scientific knowledge,
including social media, articles not yet peer-reviewed,
recommendations of empiric therapy based on very
thin evidence (often changing overnight), and lots of
buzz on presumed pathophysiology. We argue that our
case is a reminder of the necessity, even during global
emergencies, to support scientific statements with
reproducible evidence, and to rigorously distinguish
between observation, association, and causal relation-
ship. Indeed, failure to do so harbors the risk of trans-
lating questionable theories of disease pathogenesis into
therapeutic trials with potential harm to patients.
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